Patents by Inventor Barbara JEAN MASON

Barbara JEAN MASON has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20210322443
    Abstract: The present invention relates to the use of non-bioconvertible C3-substituted pregnenolone derivatives of formula (I), with no significant affinity for hormonal receptors or receptors of the central nervous system, in the treatment of substance use disorders, and in particular of alcohol use disorder.
    Type: Application
    Filed: June 29, 2021
    Publication date: October 21, 2021
    Applicant: MAPREG
    Inventors: George F. KOOB, Barbara JEAN MASON, Olivier GEORGE, Etienne BAULIEU, Isabelle VILLEY
  • Patent number: 11077122
    Abstract: The present invention relates to the use of non-bioconvertible C3-substituted pregnenolone derivatives of formula (I), with no significant affinity for hormonal receptors or receptors of the central nervous system, in the treatment of substance use disorders, and in particular of alcohol use disorder.
    Type: Grant
    Filed: November 4, 2016
    Date of Patent: August 3, 2021
    Assignee: MAPREG
    Inventors: George F. Koob, Barbara Jean Mason, Olivier George, Etienne Baulieu, Isabelle Villey
  • Publication number: 20180318317
    Abstract: The present invention relates to the use of non-bioconvertible C3-substituted pregnenolone derivatives of formula (I), with no significant affinity for hormonal receptors or receptors of the central nervous system, in the treatment of substance use disorders, and in particular of alcohol use disorder.
    Type: Application
    Filed: November 4, 2016
    Publication date: November 8, 2018
    Inventors: George F. KOOB, Barbara JEAN MASON, Olivier GEORGE, Etienne BAULIEU, Isabelle VILLEY